Skip to content

Opening book details…

About this Medicine article

323 Systemic administration of ladiratuzumab vedotin alone or in combination with pembrolizumab results in significant immune activation in the tumor microenvironment in metastatic breast cancer patients by Pusztai, Lajos ;Lu, Hailing ;Hale, Christopher ;Grosse-Wilde, Anne ;Specht, Jennifer ;Modi, Shanu ;Han, Hyo ;Cortes, Javier ;Oliveira, Mafalda ;Garfin, Phillip ;Wang, Zejing ;Onsum, Matthew is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Pusztai, Lajos ;Lu, Hailing ;Hale, Christopher ;Grosse-Wilde, Anne ;Specht, Jennifer ;Modi, Shanu ;Han, Hyo ;Cortes, Javier ;Oliveira, Mafalda ;Garfin, Phillip ;Wang, Zejing ;Onsum, Matthew
Publisher
BMJ
Published
2020
Field
Medicine (Health Sciences)

More by Pusztai, Lajos ;Lu, Hailing ;Hale, Christopher ;Grosse-Wilde, Anne ;Specht, Jennifer ;Modi, Shanu ;Han, Hyo ;Cortes, Javier ;Oliveira, Mafalda ;Garfin, Phillip ;Wang, Zejing ;Onsum, Matthew

Browse all works by Pusztai, Lajos ;Lu, Hailing ;Hale, Christopher ;Grosse-Wilde, Anne ;Specht, Jennifer ;Modi, Shanu ;Han, Hyo ;Cortes, Javier ;Oliveira, Mafalda ;Garfin, Phillip ;Wang, Zejing ;Onsum, Matthew